Thousand Oaks, CA, United States of America

Naoki Nakayama

This inventor holds 4 USPTO granted patents. Top assignee: Amgen Inc.. Active years: 2006-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naoki Nakayama. Retrieved from https://idiyas.com/inventor/naoki-nakayama-ncuwpdb0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 25.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2006-2010

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Naoki Nakayama in Biotechnology**

Introduction

Naoki Nakayama, an accomplished inventor based in Thousand Oaks, CA, has made significant strides in the biotechnology field. With a remarkable portfolio of four patents to his name, his innovations are paving the way for advancements in medical treatments and diagnostic methods.

Latest Patents

Among Nakayama's notable contributions is his work on chordin-like molecules. His latest patents describe chordin-like (CHL) polypeptides and the nucleic acid sequences that encode them. This invention encompasses selective binding agents, vectors, and host cells designed for the production of CHL polypeptides. Notably, it includes pharmaceutical compositions and methodologies aimed at the diagnosis, treatment, amelioration, and prevention of various diseases and disorders associated with these molecules. The potential applications of these innovations could lead to significant improvements in therapeutics.

Career Highlights

Nakayama is currently associated with Amgen Inc., a leading biotechnology company known for its commitment to advancing medical science through innovation. His work at Amgen has allowed him to apply his inventive skills in a collaborative environment, contributing to the company's mission of developing meaningful therapies for serious illnesses.

Collaborations

Throughout his career, Nakayama has collaborated with esteemed colleagues such as Duanzhi Wen and Chun-ya Han. These collaborations highlight the importance of teamwork in driving innovation and advancing research in the biotechnology sector. Together, they contribute to a culture of creativity and progress in their respective fields.

Conclusion

Naoki Nakayama's innovative endeavors in the realm of biotechnology represent a significant leap forward in the development of therapeutic solutions. His patents and contributions at Amgen Inc. underscore the vital role that inventors play in shaping the future of medicine. As research and technology continue to evolve, Nakayama's work illustrates the impact of dedicated individuals in advancing health and wellness on a global scale.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…